Samuel Bowman headshot

Founding Editor at Works in Progress

Sam Bowman is a founding editor of Works in Progress. Previously, he was director of competition policy at the ICLE, principal at Fingleton, and executive director of the Adam Smith Institute.

Innovation

EU Health Care, Mergers & Merger Enforcement

Popular Media

It’s in UK’s interest for Ireland to reach herd immunity

After a disastrous pandemic response that led to one of the worst death rates in the world, the UK’s vaccination programme is finally giving it something to be cheerful about. The UK bought early and broadly, prioritising speed and betting that – although it did not yet know which vaccines would work – at least some would make the cut. These early investments made it possible for vaccine manufacturers to invest in more production capacity early on.

In contrast, the EU was slow, prioritised cost reductions, refused to waive liability for vaccine firms if something went wrong, and focused on a smaller number of vaccines – some of which, like France’s Sanofi vaccines, have suffered setbacks.

Read the full piece here.